REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 191 filers reported holding REVOLUTION MEDICINES INC in Q4 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $420,985 | -35.6% | 15,209 | -44.6% | 0.02% | -54.3% |
Q4 2022 | $654,002 | -47.4% | 27,456 | -57.0% | 0.04% | -35.2% |
Q2 2022 | $1,243,000 | -28.2% | 63,800 | -5.9% | 0.05% | -27.0% |
Q1 2022 | $1,730,000 | +187.4% | 67,800 | +183.7% | 0.07% | +94.7% |
Q4 2021 | $602,000 | +8.5% | 23,900 | +70.5% | 0.04% | -59.6% |
Q4 2020 | $555,000 | – | 14,016 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 1,909,317 | $75,590,000 | 52.65% |
TRV GP III, LLC | 7,024,031 | $278,081,000 | 23.88% |
Ponoi II Management, LLC | 685,011 | $27,120,000 | 19.76% |
TRV GP IV, LLC | 1,419,900 | $56,214,000 | 18.03% |
Ponoi Management, LLC | 685,011 | $27,120,000 | 15.52% |
Column Group LLC | 3,580,252 | $141,742,000 | 12.86% |
BVF INC/IL | 2,768,049 | $109,587,000 | 4.31% |
Boxer Capital, LLC | 3,309,264 | $131,014,000 | 4.21% |
Cormorant Asset Management, LP | 2,495,066 | $98,780,000 | 2.35% |
Casdin Capital, LLC | 1,634,535 | $64,711,000 | 1.92% |